natgillin/translations-raw huggingface dataset:
A specific action will promote transnational market-oriented innovation of R&D performing SMEs.
Poseben ukrep bo spodbujal nadnacionalno tržno usmerjene inovacije MSP, ki se ukvarjajo z raziskavami in razvojem.
It targets research-intensive SMEs in any sectors that also need to demonstrate their capability to commercially exploit the project results.
Namenjen je raziskovalno intenzivnim MSP v katerem koli sektorju; ta morajo izkazati tudi svojo sposobnost za tržno izkoriščanje rezultatov projektov.
The action will cover the entire field of science and technology with a bottom-up approach to fit the needs of R&D performing SMEs.
Ukrep bo obsegal celotno področje znanosti in tehnologije v skladu s pristopom od spodaj navzgor, ustrezno potrebi MSP, ki se ukvarjajo z raziskavami in razvojem.
The action will be implemented by an Article 185 TFEU initiative building on the Eurostars Programme and reorienting it along the lines stated in its interim evaluation.
Ukrep se bo izvajal v okviru pobude na podlagi člena 185 PDEU; oprt bo na program Eurostars, ki se preusmeri v skladu z usmeritvami iz vmesne ocene.
Enhancing the innovation capacity of SMEs
Krepitev inovacijskih zmogljivosti MSP
Transnational activities assisting the implementation of and complementing the SME specific measures across Horizon 2020 will be supported, notably to enhance the innovation capacity of SMEs.
Podpirane bodo nadnacionalne dejavnosti, ki pomagajo pri izvajanju in dopolnjevanju posebnih ukrepov za MSP na vseh ravneh Obzorja 2020, zlasti za krepitev inovacijske zmogljivosti MSP.
Activities may include awareness raising, information and dissemination, training and mobility activities, networking and exchange of best practices, developing high quality innovation support mechanisms and services with strong Union added value for SMEs (e.g. intellectual property and innovation management, knowledge transfer, innovative use of ICT and e-skills in SMEs), as well as assisting SMEs to connect to research and innovation partners across the Union, allowing them to spin in technology and develop their innovation capacity.
Med dejavnosti lahko spadajo ozaveščanje, obveščanje in razširjanje informacij, usposabljanje in ukrepi za mobilnost, povezovanje v mreže in izmenjava najboljših praks, razvoj visokokakovostnih podpornih mehanizmov in storitev za inovacije z veliko dodano vrednostjo Unije za MSP (npr. upravljanje intelektualne lastnine in inovacij, prenos znanja, inovativna uporaba IKT in e-znanje v malih in srednje velikih podjetjih) ter pomoč MSP, da se pri raziskavah in inovacijah povežejo s partnerji iz celotne Unije, kar jim omogoča, da vanje vključijo tehnologije in razvijejo inovacijske zmogljivosti.
Intermediary organisations representing groups of innovative SMEs shall be invited to conduct cross-sectoral and cross-regional innovation activities with SMEs having mutually reinforcing competences, in order to develop new industrial value chains.
Posredniške organizacije, ki zastopajo skupine inovativnih MSP, se pozivajo k izvajanju medsektorskih in medregionalnih inovacijskih dejavnosti z MSP, ki imajo vzajemno okrepljene sposobnosti, da bi se tako razvile nove industrijske verige ustvarjanja vrednosti.
These activities shall be coordinated with similar national measures when appropriate.
Te dejavnosti so po potrebi usklajene s podobnimi nacionalnimi ukrepi.
Close cooperation with the National Contact Point (NCP) Network is envisaged.
Predvideno je tesno sodelovanje z mrežo nacionalnih kontaktnih točk.
Synergies with Union cohesion policy will be sought in the context of national and regional innovation strategies for smart specialisation.
V okviru nacionalnih in regionalnih inovacijskih strategij za pametno specializacijo se bodo spodbujale sinergije s kohezijsko politiko Unije.
A reinforced link with the Enterprise Europe Network (EEN) (under COSME) is envisaged ensuring its coordination with the National Contact Points.
Načrtovana je močna povezava z mrežo Enterprise Europe Network (v okviru COSME), ki naj bi zagotovila njeno usklajevanje z nacionalnimi kontaktnimi točkami.
The support could range from improved information and advisory services through mentoring, coaching and partner search activities for SMEs wishing to develop cross-border innovation projects, to providing innovation support services.
Podpora lahko sega od izboljšanih informacij in svetovalnih storitev z mentorstvom, svetovanjem in iskanjem partnerjev za MSP, ki želijo razviti čezmejne inovacijske projekte, vse do zagotavljanja podpornih inovacijskih storitev.
This will consolidate the 'one stop shop' approach of the Enterprise Europe Network to supporting SMEs, together with a strong regional and local presence of the network.
To bo utrdilo pristop „vse na enem mestu“, ki je značilen za podporo MSP v okviru mreže Enterprise Europe Network, pri čemer je mreža močno prisotna že na regionalni in lokalni ravni.
Supporting market-driven innovation
Podpora tržno naravnanih inovacij
These activities will support transnational market-driven innovation in view of enhancing the innovation capacity of SMEs by improving the framework conditions for innovation as well as tackling the specific barriers preventing the growth of innovative SMEs with potential for fast growth.
Te dejavnosti bodo spodbudile tržno naravnane inovacije, kar naj bi privedlo do okrepitve inovacijske zmogljivosti MSP, in sicer z izboljšanjem okvirnih pogojev za inovacije ter odpravo posebnih ovir, ki preprečujejo rast inovativnih MSP s potencialom za hitro rast.
Specialised innovation support (on e.g. exploitation of intellectual property, networks of procurers, support to technology transfer offices, and strategic design) and reviews of public policies in relation to innovation will be supported.
Prav tako se podpirajo posebne storitve za spodbujanje inovacij (npr. uporaba intelektualne lastnine, mreže za javno oddajanje naročil, podpiranje uradov za prenos tehnologije, strateško načrtovanje) ter pregledi javnih inovacijskih politik.
SOCIETAL CHALLENGES
DRUŽBENI IZZIVI
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING
ZDRAVJE, DEMOGRAFSKE SPREMEMBE IN DOBRO POČUTJE
Effective health promotion, supported by a robust evidence base, prevents disease, contributes to well-being and is cost-effective.
Učinkovita promocija zdravja, podprta s trdno znanstveno podlago, preprečuje bolezni, prispeva k dobremu počutju in je stroškovno učinkovita.
Promotion of health, active ageing, well-being and disease prevention also depend on an understanding of the determinants of health, on effective preventive tools, such as vaccines, on effective health and disease surveillance and preparedness, and on effective screening programmes.
Promocija zdravja, aktivnega staranja, dobrega počutja in preprečevanja bolezni je odvisna tudi od razumevanja determinant zdravja, učinkovitih preventivnih orodij, kot so cepiva, učinkovitega spremljanja zdravja in bolezni ter pripravljenosti na bolezni, pa tudi od učinkovitih presejalnih programov.
Successful efforts to prevent, detect early, manage, treat and cure disease, disability, frailty and reduced functionality are underpinned by the fundamental understanding of their causes, processes and impacts, as well as factors underlying good health and well-being.
Uspešno prizadevanje za preprečevanje, zgodnje odkrivanje, obvladovanje in zdravljenje bolezni, invalidnosti, slabotnosti in zmanjšane funkcionalnosti sloni na temeljnem poznavanju vzrokov, procesov in vplivov, pa tudi dejavnikov, na katerih temeljita dobro zdravje in dobro počutje.
Improved understanding of health and disease will demand close linkage between fundamental, clinical, epidemiological and socio-economic research.
Zaradi boljšega razumevanja zdravja in bolezni bo treba vzpostaviti tesno povezavo med temeljnimi, kliničnimi, epidemiološkimi in družbeno-ekonomskimi raziskavami.
Effective sharing of data and the linkage of these data with real-world large-scale cohort studies is also essential, as is the translation of research findings into the clinic, in particular through the conduct of clinical trials.
Učinkovita izmenjava podatkov in povezovanje teh podatkov z realnimi obsežnimi kohortnimi študijami sta prav tako bistvenega pomena, enako kot prenos rezultatov raziskav v klinično prakso, zlasti s kliničnimi študijami.
It is a societal challenge to adjust to the further demands on health and care sectors due to the ageing population.
Prilagoditev novim zahtevam za zdravstveni sektor in sektor oskrbe zaradi staranja prebivalstva pomeni družbeni izziv.
If effective health and care is to be maintained for all ages, efforts are required to improve and speed up decision making in prevention and treatment provision, to identify and support the dissemination of best practice in the health and care sector, to raise awareness and to support integrated care.
Če naj bi se učinkovito zdravstvo in oskrba ohranila za vsa starostna obdobja, si je treba prizadevati za boljše in hitrejše sprejemanje odločitev na področju zagotavljanja preventive in zdravljenja, za opredelitev in podporo razširjanju najboljše prakse v zdravstvenem varstvu, da bi izboljšali ozaveščenost ter za podporo celostni oskrbi.
A better understanding of ageing processes and the prevention of age-related illnesses are the basis for keeping European citizens healthy and active throughout the course of their lives.
Boljše razumevanje procesa staranja in preprečevanje s starostjo povezanih bolezni sta temelj za to, da evropski državljani ostanejo zdravi in aktivni vse življenje.
Similarly important is the wide uptake of technological, organisational and social innovations empowering older persons, persons with chronic diseases as well as disabled persons, to remain active and independent.
Enako pomembna je široka uporaba tehnoloških, organizacijskih in družbenih inovacij, ki zlasti starejšim, kroničnim bolnikom in invalidom pomagajo, da ostanejo dejavni in samostojni.
Doing so will contribute to increasing their physical, social, and mental well-being and lengthening the duration thereof.
To bo prispevalo k izboljšanju in podaljšanju fizičnega, socialnega in duševnega dobrega počutja.
This specific objective should address in the relevant activities chronic conditions and diseases including but not limited to:
Ta posebni cilj bi moral v ustreznih dejavnostih obravnavati kronična stanja in bolezni, ki med drugim vključujejo:
cardiovascular disease, cancer, metabolic diseases and risk factors including diabetes, chronic pain, neurological, neurodegenerative, mental health and substance use disorders, rare diseases, overweight and obesity, autoimmune diseases, rheumatic and musculo-skeletal disorders and various diseases affecting different organs as well as acute conditions and various functional limitations.
bolezni srca in ožilja, raka, presnovne bolezni in dejavnike tveganja, vključno s sladkorno boleznijo, kronično bolečino, nevrološke in nevrodegenerativne motnje, motnje duševnega zdravja in zdravstvene motnje zaradi uživanja psihoaktivnih snovi, redke bolezni, prekomerno težo in debelost, avtoimunske bolezni, revmatična in kostno-mišična obolenja ter različne bolezni, ki prizadenejo posamezne organe, pa tudi akutna stanja in različne funkcionalne omejitve.
Likewise infectious diseases, including but not limited to HIV/AIDS, tuberculosis and malaria, neglected and poverty related diseases and animal-borne diseases, emerging epidemics, re-emerging infectious diseases (including water-related diseases) as well as the threat of increasing anti-microbial resistance and occupational diseases and work related disorders should be addressed.
Obravnavati bi moral tudi nalezljive bolezni, ki med drugim vključujejo HIV/AIDS, tuberkulozo in malarijo, zapostavljene bolezni in bolezni, povezane z revščino, ter bolezni, ki jih prenašajo živali, nove epidemije, ponovno pojavljajoče se nalezljive bolezni (tudi z vodo povezane bolezni), pa tudi nevarnost večanja protimikrobne odpornosti ter poklicne bolezni in bolezni, povezane z delom.
Personalised medicine should be developed in order to suit preventive and therapeutic approaches to patient requirements, and must be underpinned by the early detection of disease.
Z razvijanjem posamezniku prilagojene medicine naj bi bili upoštevani preventivni in terapevtski pristopi k pacientovim potrebam, vendar mora tovrstna medicina temeljiti na zgodnjem odkrivanju bolezni.
All of these activities will be undertaken in such a way as to provide support throughout the research and innovation cycle, strengthening the competitiveness of the European based industries and development of new market opportunities.
Vse te dejavnosti se izvajajo na način, ki zagotavlja podporo v celotnem ciklusu raziskav in inovacij, zaradi česar se okrepita tudi konkurenčnost industrijskih panog v Evropi in razvoj novih tržnih priložnosti.
Support will be given to translational approaches that integrate several steps of the innovation process in the health care industry.
Podpora bo namenjena translacijskim pristopom, ki združujejo več korakov inovacijskega procesa v sektorju zdravstvenega varstva.
Specific activities are described below.
Posebne dejavnosti so opisane v nadaljevanju.
Understanding health, well-being and disease
Razumevanje zdravja, dobrega počutja in bolezni
Understanding the determinants of health, improving health promotion and disease prevention
Razumevanje determinant zdravja, izboljšanje promocije zdravja in preprečevanje bolezni
A better understanding of the determinants of health is required in order to provide evidence for effective health promotion and disease prevention, and will also allow the development of comprehensive health and well-being indicators in the Union based on existing data sources and indicator systems.
Boljše razumevanje determinant zdravja je potrebno, da se zagotovi znanstvena podlaga za učinkovito promocijo zdravja in preprečevanje bolezni, omogočilo pa bo tudi razvoj celovitih kazalnikov zdravja in dobrega počutja v Uniji na podlagi obstoječih podatkovnih virov in sistemov kazalnikov.
Environmental, behavioural (including life-style), psychological, organisational, cultural, socio-economic, biological and genetic factors, in their broadest senses, will be studied.
Preučevali se bodo okoljski, vedenjski (vključno z življenjskim slogom), psihološki, organizacijski, kulturni, družbeno-ekonomski, biološki in genetski dejavniki v najširšem smislu.
Approaches will include the long term study of cohorts and their linkage with data derived from "omics" research, systems bio-medicine including relevant applications of systems biology and other methods.
Sem spadajo tudi dolgoročne kohortne študije in njihova povezanost s podatki, pridobljenimi z raziskavami na področjih, katerih poimenovanja se končujejo z „-omika“, sistemsko biomedicino, vključno z ustrezno uporabo sistemske biologije, in drugimi metodami.
In particular, a better understanding of the environment as a determinant of health will require an interdisciplinary approach integrating amongst others human-relevant molecular biological, epidemiological and toxicological approaches and resultant data to study the modes of action of various chemicals, combined exposures to pollutants and other environmental and climate-related stressors, to perform integrated toxicological testing and to seek alternatives to animal testing.
Za boljše razumevanje okolja kot determinante zdravja bo potreben meddisciplinaren pristop, ki med drugim vključuje molekularnobiološki, epidemiološki in toksikološki pristop, ki zadeva ljudi, in z njim pridobljene podatke za raziskovanje delovanja različnih kemikalij, istočasni izpostavljenosti onesnaževalom ter drugim z okoljem in podnebjem povezanim dejavnikom stresa, za integrirano toksikološko preskušanje ter iskanje alternativ za poskuse na živalih.
Innovative approaches to exposure assessment are needed using new-generation biomarkers based on 'omics' and epigenetics, human biomonitoring, personal exposure assessments and modelling to understand combined, cumulative and emerging exposures, integrating socio-economic, cultural, occupational, psychological and behavioural factors.
Potrebni so inovativni pristopi za ocenjevanje izpostavljenosti, pri katerih se uporabljajo biološki označevalci nove generacije, ki temeljijo na „-omikah“ in epigenetiki, biološko spremljanje ljudi ter individualne ocene izpostavljenosti in modeliranja za razumevanje kombiniranih, kumulativnih in nastajajočih izpostavljenosti, upoštevajoč družbeno-gospodarske, kulturne, poklicne, psihološke in vedenjske dejavnike.
Improved links with environmental data using advanced information systems will be supported.
Podpiral se bo boljši dostop do okoljskih podatkov z uporabo naprednih informacijskih sistemov.
In this way, existing and planned policies and programmes can be assessed and policy support provided.
Na ta način se lahko ocenijo obstoječe in načrtovane politike in programi ter zagotovi podpora politiki.
Similarly, improved behavioural interventions, prevention and education programmes can be developed, including those pertaining to health literacy in nutrition, physical activity, vaccination and other primary care interventions.
Podobno se lahko razvijejo boljša vedenjska terapija ter preventivni in izobraževalni programi, vključno s tistimi za boljšo zdravstveno ozaveščenost o prehrani, telesni dejavnosti, cepljenju in drugih ukrepih osnovnega zdravstva.
Understanding disease
Razumevanje bolezni
There is a need for an improved understanding of health and disease, throughout the human life cycle, so that new and better prevention measures, diagnosis, treatments and rehabilitation measures can be developed.
Izboljšati je treba razumevanje zdravja in bolezni v celotnem življenjskem ciklu, da se lahko razvijejo novi in boljši ukrepi za preprečevanje, diagnosticiranje, zdravljenje in rehabilitacijo.
Interdisciplinary, basic and translational research on the patho-physiology of disease is essential to improve the understanding of all aspects of disease processes, including a re-classification of normal variation and disease based on molecular data, and to validate and use research results in clinical applications.
Meddisciplinarne, temeljne in translacijske raziskave o patofiziologiji bolezni so bistvenega pomena za boljše razumevanje vseh vidikov bolezenskih procesov, vključno z novo določitvijo mej med normalnimi variacijami in boleznijo na osnovi molekularnih podatkov, ter za potrjevanje in uporabo rezultatov raziskav v klinični praksi.
Underpinning research will encompass and encourage development and use of new tools and approaches for the generation of biomedical data and will include bio-imaging, "omics", high throughput and systems medicine approaches.
Podporne raziskave bodo zajemale in spodbujale razvoj in uporabo novih orodij in pristopov za pridobivanje biomedicinskih podatkov, med drugim bioslikanja, „-omik“, pristopov z veliko prebojnostjo in sistemsko-medicinskih pristopov.
These activities will demand close linkage between fundamental and clinical research and with long term cohort studies (and the corresponding research domains) as described above.
Pri teh dejavnostih bo potrebna tesna povezanost temeljnih in kliničnih raziskav ter dolgoročnih kohortnih študij (in ustreznih raziskovalnih področij), kot je opisano zgoraj.
Close links with research and medical infrastructures (databases, bio-banks etc.) will also be required for standardisation, storage, sharing and access to data, which are all essential for maximising data utility and for stimulating more innovative and effective ways of analysing and combining datasets.
Za standardizacijo, shranjevanje, izmenjavo in dostop do podatkov, ki so bistveni za povečanje njihove uporabnosti ter spodbujanje bolj inovativnih in učinkovitih načinov za analiziranje in združevanje podatkovnih nizov, bo potrebna tudi tesna povezanost z raziskovalno in medicinsko infrastrukturo (zbirkami podatkov, biobankami itd.).
Improving surveillance and preparedness
Izboljšanje spremljanja in pripravljenosti
Human populations are under threat from new and emerging infections, including of zoonotic origin, as well as from those which result from drug resistance to existing pathogens and from other direct and indirect consequences of climate change and from the international movement of people.
Človeštvo ogrožajo nove in nastajajoče okužbe, vključno s tistimi, ki jih povzročajo zoonoze, pa tudi tistimi, ki nastajajo zaradi odpornosti obstoječih povzročiteljev bolezni na zdravila ter drugih neposrednih in posrednih posledic podnebnih sprememb in mednarodnega gibanja ljudi.
New or improved methods for surveillance, diagnosis, early warning networks, health service organisation and preparedness campaigns are needed for the modelling of epidemics and for effective pandemic response.
Za modeliranje epidemij in učinkovit odziv na pandemije so potrebne nove ali boljše metode za spremljanje, diagnosticiranje, mreže za zgodnje opozarjanje, organizacijo zdravstvenih storitev ter pripravljalne kampanje.
Efforts to maintain and enhance capabilities to combat drug-resistant infectious diseases are also needed.
Potrebno je tudi prizadevanja za ohranitev in okrepitev zmogljivosti za boj proti nalezljivim boleznim, ki so odporna na zdravila.
Preventing disease
Preprečevanje bolezni
Developing effective prevention and screening programmes and improving the assessment of disease susceptibility
Razvoj učinkovitih preventivnih in presejalnih programov ter boljša ocena dovzetnosti za bolezni
The development of prevention and screening programmes depends on the identification of early biomarkers (including functional and behavioural) of risk and of disease onset, and their design should be informed by internationally accepted criteria.
Razvoj preventivnih in presejalnih programov je odvisen od določanja bioloških označevalcev tveganja in začetka bolezni (vključno s funkcionalnimi in vedenjskimi), oblikovani pa bi morali biti na podlagi mednarodno sprejetih meril.
Their deployment depends on the testing and validation of screening methods and programmes.
Pred njihovo uporabo pa je treba presejalne metode in programe preskusiti in potrditi.
Knowledge should be generated and methods developed for identifying individuals and populations at a clinically relevant increased risk of disease.
Pridobiti bi bilo treba znanje in razviti metode za prepoznavanje posameznikov in populacij, pri katerih obstaja klinično relevantno povečano tveganje za bolezen.
Identifying individuals and populations at high risk of disease will allow personalised, stratified and collective strategies for efficacious and cost-effective disease prevention to be developed.
Določitev posameznikov in populacij, za katere obstaja visoko tveganje bolezni, bo omogočila razvoj individualnih, stratificiranih in skupnih strategij za uspešno in stroškovno učinkovito preprečevanje bolezni.
Improving diagnosis and prognosis
Izboljšanje diagnoz in prognoz
An improved understanding of health, disease and disease processes throughout the life cycle is needed to develop new and more effective diagnostics and theranostics.
Potrebno je boljše razumevanje zdravja, bolezni in bolezenskih procesov v celotnem življenjskem ciklusu, da se razvijejo nove in učinkovitejše diagnostične in teranostične metode.
Innovative and existing methods, technologies and tools will be developed with the goal of significantly improving disease outcomes through earlier, more accurate diagnosis and prognosis and by allowing for accessible, more patient-adapted, treatment.
Razvite bodo nove in obstoječe metode, tehnologije in orodja, ki naj bi z zgodnejšo in natančnejšo diagnozo in prognozo ter dostopnim in pacientu prilagojenim zdravljenjem bistveno izboljšale rezultate pri posameznih boleznih.
Developing better preventive and therapeutic vaccines
Razvoj boljših preventivnih in terapevtskih cepiv